Pfizer Inc. (PFE)
USD 25.89
(-2.04%)
USD 25.89
(-2.04%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 58.49 Billion | 100.33 Billion | 81.28 Billion | 41.9 Billion | 51.75 Billion | 53.64 Billion |
| Cost of Revenue | 29.68 Billion | 34.34 Billion | 30.82 Billion | 8.69 Billion | 10.21 Billion | 11.24 Billion |
| Gross Profit | 28.8 Billion | 65.98 Billion | 50.46 Billion | 33.21 Billion | 41.53 Billion | 42.39 Billion |
| Operating Expenses | 25.45 Billion | 28.71 Billion | 30.23 Billion | 24.45 Billion | 27.61 Billion | 27.35 Billion |
| Selling, General and Administrative Expenses | 14.77 Billion | 13.67 Billion | 12.7 Billion | 11.61 Billion | 14.35 Billion | 14.45 Billion |
| Research and Development Expenses | 10.67 Billion | 11.42 Billion | 13.82 Billion | 9.4 Billion | 8.65 Billion | 8 Billion |
| Other Expenses | - | 3.6 Billion | 3.7 Billion | 3.43 Billion | 4.61 Billion | 1.14 Billion |
| Cost and Expenses | 55.13 Billion | 63.05 Billion | 61.05 Billion | 33.14 Billion | 37.82 Billion | 38.6 Billion |
| Operating Income | 3.35 Billion | 40.03 Billion | 24.83 Billion | 10.63 Billion | 15.13 Billion | 15.04 Billion |
| Interest Expense | 2.2 Billion | 1.23 Billion | 1.29 Billion | 1.44 Billion | 1.57 Billion | 1.31 Billion |
| Income Tax Expense | -1.11 Billion | 3.32 Billion | 1.85 Billion | 477 Million | 1.38 Billion | 706 Million |
| Earnings before Tax | 1.05 Billion | 34.72 Billion | 24.31 Billion | 7.49 Billion | 17.68 Billion | 11.88 Billion |
| Net Income | 2.11 Billion | 31.37 Billion | 21.97 Billion | 7.02 Billion | 16.27 Billion | 11.15 Billion |
| Earnings Per Share Basic | 0.38 | 5.59 | 3.95 | 1.26 | 2.92 | 1.90 |
| Earnings Per Share Diluted | 0.37 | 5.47 | 3.88 | 1.25 | 2.87 | 1.87 |
| Weighted Average Shares Outstanding | 5.64 Billion | 5.6 Billion | 5.6 Billion | 5.55 Billion | 5.56 Billion | 5.87 Billion |
| Weighted Average Shares Outstanding (Diluted) | 5.7 Billion | 5.73 Billion | 5.7 Billion | 5.63 Billion | 5.67 Billion | 5.97 Billion |
| Gross Margin | 0.49 | 0.66 | 0.62 | 0.79 | 0.80 | 0.79 |
| EBIT Margin | 0.16 | 0.43 | 0.35 | 0.34 | 0.38 | 0.40 |
| Profit Margin | 0.04 | 0.31 | 0.27 | 0.17 | 0.31 | 0.21 |
| EBITDA | 9.55 Billion | 41.03 Billion | 30.79 Billion | 13.16 Billion | 18.85 Billion | 19.58 Billion |
| Earnings Before Tax Margin | 0.06 | 0.40 | 0.31 | 0.25 | 0.29 | 0.28 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 17.7 Billion | 13.28 Billion | 14.87 Billion | 58.49 Billion | 14.24 Billion | 13.23 Billion |
| Cost of Revenue | 5.26 Billion | 5.04 Billion | 4.38 Billion | 29.21 Billion | 8.59 Billion | 10.6 Billion |
| Gross Profit | 12.43 Billion | 8.24 Billion | 10.49 Billion | 29.28 Billion | 5.65 Billion | 2.62 Billion |
| Operating Expenses | 7.15 Billion | 6.36 Billion | 5.93 Billion | 25.04 Billion | 7.25 Billion | 5.89 Billion |
| Selling, General and Administrative Expenses | 3.24 Billion | 3.68 Billion | 3.45 Billion | - | 4.47 Billion | 3.21 Billion |
| Research and Development Expenses | 2.59 Billion | 2.67 Billion | 2.48 Billion | - | 2.77 Billion | 2.68 Billion |
| Other Expenses | -1.31 Billion | 230 Million | 361 Million | 2.67 Billion | 1.03 Billion | 574 Million |
| Cost and Expenses | 12.41 Billion | 11.4 Billion | 10.32 Billion | 54.26 Billion | 15.84 Billion | 16.49 Billion |
| Operating Income | 5.28 Billion | 1.87 Billion | 4.55 Billion | 4.23 Billion | -1.59 Billion | -3.26 Billion |
| Interest Expense | 783 Million | 778 Million | 790 Million | 2.36 Billion | 688 Million | 695 Million |
| Income Tax Expense | 234 Million | -134 Million | 293 Million | -1.11 Billion | -794 Million | -964 Million |
| Earnings before Tax | 4.71 Billion | -103 Million | 3.42 Billion | 1.05 Billion | -4.12 Billion | -3.35 Billion |
| Net Income | 4.46 Billion | 24 Million | 3.11 Billion | 2.11 Billion | -3.34 Billion | -2.39 Billion |
| Earnings Per Share Basic | 0.79 | 0.00 | 0.55 | - | -0.59 | -0.42 |
| Earnings Per Share Diluted | 0.78 | 0.00 | 0.55 | - | -0.59 | -0.42 |
| Weighted Average Shares Outstanding | 5.66 Billion | 5.66 Billion | 5.65 Billion | 5.64 Billion | 5.64 Billion | 5.64 Billion |
| Weighted Average Shares Outstanding (Diluted) | 5.7 Billion | 5.69 Billion | 5.69 Billion | 5.7 Billion | 5.64 Billion | 5.64 Billion |
| Gross Margin | 0.70 | 0.62 | 0.71 | 0.50 | 0.40 | 0.20 |
| EBIT Margin | 0.31 | 0.27 | 0.42 | - | 0.01 | -0.13 |
| Profit Margin | 0.25 | 0.00 | 0.21 | 0.04 | -0.23 | -0.18 |
| EBITDA | 5.5 Billion | 3.61 Billion | 6.29 Billion | - | 77 Million | -1.7 Billion |
| Earnings Before Tax Margin | 0.30 | 0.14 | 0.31 | 0.07 | -0.11 | -0.25 |
AUHIF
FAR
SILGO
600346
JACKSON
3K-BAT